Axa’s PotlatchDeltic PCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-61,000
Closed -$2.68M 1160
2022
Q4
$2.68M Sell
61,000
-1,700
-3% -$76.9K 0.01% 729
2022
Q3
$2.57M Buy
62,700
+4,000
+7% +$184K 0.01% 721
2022
Q2
$2.59M Sell
58,700
-15,600
-21% -$805K 0.01% 729
2022
Q1
$3.92M Buy
74,300
+14,000
+23% +$764K 0.01% 712
2021
Q4
$3.63M Sell
60,300
-30,800
-34% -$1.73M 0.01% 741
2021
Q3
$4.7M Buy
91,100
+100
+0.1% +$5.22K 0.01% 697
2021
Q2
$4.84M Buy
91,000
+49,500
+119% +$2.85M 0.01% 717
2021
Q1
$2.2M Buy
+41,500
New +$2.14M 0.01% 831
2019
Q3
Sell
-24,200
Closed -$943K 1340
2019
Q2
$943K Sell
24,200
-7,000
-22% -$263K ﹤0.01% 987
2019
Q1
$1.18M Buy
+31,200
New +$1.11M ﹤0.01% 941
2016
Q1
Sell
-5,887
Closed -$178K 1384
2015
Q4
$178K Hold
5,887
﹤0.01% 1189
2015
Q3
$169K Sell
5,887
-1,085
-16% -$36.4K ﹤0.01% 1238
2015
Q2
$246K Buy
+6,972
New +$257K ﹤0.01% 1198

Other funds holding PCH

Axa's PCH Position: Q1 2023 in Review

Axa sold out of PotlatchDeltic (PCH) in Q1 2023, closing a stake of 61,000 shares — an estimated $2.68M sold.

Axa first reported a position in PCH in Q2 2015 and held it in 13 quarters. The position peaked at $4.84M in Q2 2021. 335 funds tracked by Wall St. Rank hold PCH as of Q1 2023.

  • Axa reported no remaining PotlatchDeltic position as of Q1 2023 after selling out during the quarter.
  • Axa sold 61,000 PotlatchDeltic shares in Q1 2023, an estimated $2.68M.
  • Axa first reported a position in PotlatchDeltic in Q2 2015 and held it in 13 quarters.
  • Axa's PotlatchDeltic position peaked at $4.84M in Q2 2021.
  • 335 funds tracked by Wall St. Rank held PotlatchDeltic as of Q1 2023.

Based on Axa's 13F filing for Q1 2023, filed 15 May 2023.